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Abstract 
Meningioma in vivo research is slowed by the difficulty of establishing an easy and reproducible orthotopic 
model able to mimic the characteristics of a human meningioma. Moreover, leptomeningeal dissemination 
and high mortality is often associated with this kind of orthotopical models, making them useless for clinical 
translation studies.1-2An optimized method to induce meningioma on nude mice in two different sites is 
described in this paper, proving its high reproducibility and low mortality. Skull Base Meningioma was 
induced into the auditory meatus, while the Convexity was induced on the brain surface of 23 and 24 nude 
mice, respectively. Both models lead to the development of a mass easily observable by imaging methods. 
Dynamic Contrast Enhanced (DCE) MRI was used as a tool to monitor and characterize the pathology onset 
and progression. At the end of the study, histology was performed to confirm the neoplastic origin of the 
diseased mass. 
Introduction 
This study focuses on the induction of two orthotopic meningioma models: Skull Base of the auditory 
meatus, and Convexity Meningioma. The models were selected as an example of meningioma tumor in mice, 
to be used in preclinical studies for translational research, being meningioma one of the brain tumors with 
the highest incidence. Despite a relatively low mortality characterizes human meningioma, the development 
of early diagnostic tools and/or of effective therapies is extremely important to improve the outcome of the 
medical treatment of such pathology,  
Both models were induced by using CH157MN cell line, isolated for the first time in 1977 from a 41 years 
old woman3. This line was selected among others because of its ability to reproduce histological, 
immunohistochemical and structural features of human meningioma. CH157MN model was already 
introduced by Ragel et al in 2007 and 20084-5; nevertheless the papers were focused on the model 
characterization via luciferase rather than on the description of the induction or on the characterization by 
MRI (tumors were imaged post mortem by MRI, only to calculate tumor volume, rather than to have a 
precise localization and description of the model in real time). Similarly, Giogigeni and Karsy6-7 adopted the 
model, but they both use bioluminescence imaging to monitor tumor growth and response to treatment. In 
such manner it was possible to approximately know if the treatment was reducing the tumor mass, but not the 
precise localization and characteristics, since bioluminescence imaging lacks in resolution, not allowing to 
accurately measure the tumor burden, its depth, and localization. 
47 athymic female nude mice (5-6 weeks old) were inoculated with CH157MN cells and imaged weekly on a 
1 T scanner, before and after administration of a commercial Gadolinium Based Contrast Agent (GBCA). 
The introduction of a non-invasive method as MRI, allowed a proper evaluation of tumor growth, 
vascularization and GBCA perfusion/permeability. 
 
 PROTOCOL 
All the procedures involving animals were conducted according to the national and international laws on 
experimental animals (L.D. 26/2014; Directive 2010/63/EU). This experimental protocol was approved by 
the Italian Ministry of Health with Authorization 724/2017 PR. 
CH157MN cells were cultured in DMEM F12 with 7% FBS. For the induction, they were resuspended in 3-8 
µL of serum-free DMEM F12. 
Tumor Induction 
Mouse was subcutaneously administered with carprofen 5 mg/kg one hour before the surgery. Anesthesia 
was induced with sevoflurane gas and then systemically by Rompun® 5 mg/kg and Zoletil® 40 mg/kg. Mouse 
was then mounted on the stereotaxic apparatus and its temperature was continuously monitored and 
maintained in the range 36.5-38.5 °C. After cleaning the skin with a disinfectant, a local anesthesia was 
administered. Bregma was then exposed and the site of induction was identified by using the following 
coordinates: 3 mm anterior, 2 mm lateral to bregma and 2 mm under the frontal bone for the Convexity 
Meningioma and at the skull base (13-14 mm) for Skull Base Meningioma. A small hole was drilled 
manually, and a volume of 3-8 µL containing 5 x 104 - 5 x 105 (skull base) to 105-106 (convexity) CH157MN 
cells was released manually in approx. 1 µL/3 min by using a Hamilton syringe with 25G needle. The hole 
was closed after removing the needle, and the mouse removed from stereotaxic apparatus. For more details 
see the supplementary material. 
Imaging Protocol 
Mice were imaged once or twice a week using a 1 T Icon (Bruker) scanner. After preliminary anatomical 
scans, MSME sequences were acquired before and after the intravenous administration of the GBCA. The 
following parameters were set: Matrix size = 128 x 128, FieldOfView = 1.6 x 1.6 cm, slice thickness 1.2 
mm, TE(echo time)= 9.2 ms, TR(repetition time)= 350 ms, acquisition time = 90 s, NA = 2. 
Results 
CH157MN meningioma was induced on 47 nude mice, according to the experimental protocols summarized 
in Table 1. The induction was successful in 35/47 animals, specifically in:  
• 15/24 for Skull Base Meningioma (4 mice did not survive the systemic anesthesia and 1 showed 
clinical signs immediately after the surgery; 4 mice did not develop any tumor); 
• 20/23 for Convexity Meningioma (1 mouse did not survive the systemic anesthesia; 2 mice did not 
develop any tumor).  
As detailed in Table 1, once the inoculation site has been set, different experimental conditions were tested 
(i.e. the cell number and the method adopted to suture the surgical wound) to optimize the protocol.  
The Convexity Meningioma generally showed a better outcome than the Skull Base model, either in terms of 
success of the surgery procedure and in terms of animal welfare. Specifically, the intra-operatory mortality 
was lower for 3 over 4 groups inoculated superficially, indicating as expected a minor surgery risk, since the 
needle stops at the surface rather than passing through the brain to reach the auditory meatus. Even after 
surgery, the occurrence of clinical signs was more severe for the Skull Base model, with the appearance of 
unsteady gait, domed head and loss of equilibrium, this latter probably due to the specific location of the 
tumor in the auditory meatus. As a further advantage of the Convexity model, the tumor take rate was 
superior. Tumor volume, growth rate and maximum enhancement after GBCA administration were 
comparable between the two sites. All the different suture procedures adopted for both the Skull Base and 
Convexity Meningioma were effective to avoid the appearance of any extra-cranial mass.  
Needle with tip was used during cells inoculation only for three animals, while for all the other experimental 
groups the needle without tip was used. This choice was motivated by the fact that, only one animal over 
three inoculated using a needle with tip developed an observable tumor mass; most likely the tip avoided a 
proper release of tumor cells.  
One week after tumor induction, animals without significant or prolonged clinical signs were imaged weekly 
(or closer) by MRI and administered with a GBCA in the presence of a clearly visible tumor mass. A tumor 
mass was generally visible starting from 1 week/10 days from induction in both inoculation sites, as 
observable for representative animals in all geometrical section of T2-weighted images (Figure 1, A and B). 
T1-weighted images (pre and post contrast) together with signal enhancement vs time quantification are 
shown in panel A and B of Figure 2 for Skull Base and Convexity meningioma, respectively. In pre contrast 
images, brain tissue and tumor mass showed the same signal, but after GBCA administration the diseased 
tissue reached a higher enhancement and became clearly discernible from the contralateral region, i.e. 
auditory meatus for Skull Base Meningioma and healthy brain for Convexity Meningioma. The enhancement 
of the tumor mass was always noticeable, ranging from 50 to 120 % with few exceptions at short times after 
induction or when the tumor mass was not yet well developed.  
Finally, meningioma identity and tissue vascularization were assessed by histological analysis. Both 
CH157MN orthotopic tumors exhibited histological analogies of human grade III meningioma tumor, such 
as nuclear polymorphism, large cells with eccentric nuclei and abundant cytoplasm and mitosis (Figure 3). 
The tumors displayed infiltrative growth, widespread vascularization and, often, the presence of 
hemorrhages.   
Discussion 
The induction of two different models of orthotopic meningioma into nude mice was described. 
Skull Base Meningioma was correctly induced into the auditory meatus of female nude mice. The most 
critical steps for the appropriate induction of the meningioma into this site were:  
1) Ventral coordinate optimization to the skull base. The best coordinate was identified based on the 
fact that the needle encountered resistance when moved in the ventral position and resulted to be 14 
mm. This value stays true if the mouse used has the same strain, sex and age we described. 
2) Rate of cellular release into the auditory meatus. The volume needed to suspend the cells is really 
high, so it is important that the release happens slowly and carefully. Else, an accumulation of edema 
into the auditory meatus could cause massive clinical signs such as loss of equilibrium at the end of 
the procedure. 
Convexity Meningioma was easier to induce and overall showed less clinical signs and troubleshooting. 
However, these steps should be performed with particular care for the appropriate induction of the model: 
1. Dura mater preservation. Dura mater should not be damaged when drilling the skull, so the hole 
was drilled manually, with the use of magnifying glasses to help the operator. When the drill 
encounters less resistance, this is when the drilling has to stop.  
2. Tumor growth outside the skull. It is important to close the hole in the proper way to avoid 
extracranial tumor growth. Dental cement proved to be the more efficient choice to close the 
hole correctly. 
 
Non-invasive MRI was introduced to characterize in real time the evolution of the cerebral pathologies, even 
from early stages. The onset of the pathologies was monitored at different time points, allowing the operator 
to control the appearance and growth of the disease, as well as the permeability properties, by injection of a 
GBCA.  
The feasibility and high reproducibility of the pathological models proved them to be effective for GBCA 
validation MRI studies. The precise location of the meningioma tumors as seen on MRI proved to mimic the 
complex situations in human beings8. The noticeable enhancement obtained after GBCA administration in 
the investigated ortothopic meningiomas demonstrated that these models could be used as a “bridge” to fill 
the gap between clinical and preclinical efficacy studies. 
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Table 1: Experimental Scheme and results. 
 
Group  Total 
Animals 
Cell 
Number/Suture 
Procedure 
Site Stereotaxic 
Coordinates 
Intraoperatory 
Mortality 
Tumor 
Take 
Rate 
Average 
Tumor 
Volume 
(mm3) 
Average 
Maximum 
Enhancement 
(%) 
Clinical Signs  
1 6 5∙104 suspended 
in 3 µL, surgical 
glue to seal/suture 
both the skull 
hole and the 
wound 
Skull base Ant. 3 mm, Lat. 
2 mm, Vent. 12-
13 mm and 
needle with tip; 
Ant. 3 mm, Lat. 
2 mm, Vent. at 
skull and needle 
without tip  
 1/6 4/5  55 80 Neurological 
damage, 
unsteady gait, 
tumbling, 
apathy 
2 6 5∙105 suspended 
in 3 µL, surgical 
glue to seal/suture 
the skull hole and 
the wound 
Skull base Ant. 3 mm, Lat. 
2 mm, Vent. at 
skull and needle 
without tip 
 1/6 3/5 85 70 No 
observations 
3 6 5∙104 suspended 
in 3 µL, silk 
thread (5.0) to 
suture the wound 
Skull base Ant. 3 mm, Lat. 
2 mm, Vent. at 
skull and needle 
without tip 
 1/6 2/5 45 70 Loss body 
weight <8%, 
dyspnea, 
isolation from 
the group, 
dehydration, 
closed eye lids, 
unsteady gait 
4 6 5∙105 suspended 
in 5 µL, silk 
thread (5.0) to 
suture the wound 
Skull base Ant. 3 mm, Lat. 
2 mm, Vent. at 
skull and needle 
without tip 
2/6 4/4 50 55 Tachipnea, 
isolation from 
the group, 
immobility, 
closed lid eye, 
loss of 
coordination 
and equilibrium 
5 6 105 suspended in 
3 µL, surgical 
glue to seal/suture 
the skull hole and 
the wound 
Convexity Ant. 3 mm, Lat. 
2 mm, Vent. 2 
mm and needle 
without tip 
 1/6 5/5 62 70 Domed head 
6 5 106 suspended in 
8 µL, surgical 
glue to seal/suture 
the skull hole and 
the wound 
Convexity Ant. 3 mm, Lat. 
2 mm, Vent. 2 
mm and needle 
without tip 
0/5 4/5 50 70 No 
observations 
7 6 105 suspended in 
3 µL, bone wax to 
seal the skull hole 
and silk thread 
(5.0) to suture the 
wound 
Convexity Ant. 3 mm, Lat. 
2 mm, Vent. 2 
mm and needle 
without tip 
0/6 5/6 40 80 Domed head 
and retracted 
eyes 
8 6 106 suspended in 
a 6 µL, bone wax 
to seal the skull 
hole and silk 
thread (5.0) to 
suture the wound 
Convexity Ant. 3 mm, Lat. 
2 mm, Vent. 2 
mm and needle 
without tip  
0/6 5/6 50 60 Domed head 
and retracted 
eyes 
Figure 1. Representative anatomical T2-weighted images at different weeks post tumor 
induction in all geometrical sections (from left to right axial, coronal and sagittal). A: Skull Base 
meningioma. B: Convexity Meningioma. 
 
  
 
 
 
  
 
 
 
   
 
Figure 2. Representative contrast enhanced T1-weighted images and MSME signal enhancement 
as a function of time for healthy contralateral tissue (blue) and tumor mass (red). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
Figure 3. Representative examples of histological images of Skull Base Meningioma (A) and 
Convexity (B). 
 
 
 
